Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Puma Biotechnology, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 82 | 93 | +11 |
| Shares | 26.6M | 29.7M | +3.14M (+11.8%) |
| Value | $115.2M | $157.7M | +$42.5M (+36.8%) |
New holders (20)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 2,816,294 | $14.9M | 0.63% |
| Arrowstreet Capital, Limited Partnership | 230,425 | $1.22M | 0.00% |
| Winton Group Ltd | 188,283 | $997.9K | 0.07% |
| Wellington Management Group LLP | 170,765 | $905.1K | 0.00% |
| HRT Financial LP | 127,231 | $674.0K | 0.00% |
| Marathon Trading Investment Management LLC | 70,300 | $372.6K | 0.15% |
| EntryPoint Capital, LLC | 61,991 | $328.6K | 0.29% |
| Brevan Howard Capital Management LP | 49,875 | $264.3K | 0.02% |
| Metis Global Partners, LLC | 39,527 | $209.5K | 0.01% |
| Trexquant Investment LP | 32,199 | $170.7K | 0.00% |
| Omers Administration Corp | 16,800 | $89.0K | 0.00% |
| CTC Alternative Strategies, Ltd. | 12,100 | $64.1K | 0.04% |
| Royce & Associates LP | 11,738 | $62.2K | 0.00% |
| LMR Partners LLP | 11,006 | $58.3K | 0.00% |
| SG Americas Securities, LLC | 10,740 | $57.0K | 0.00% |
| State of Wyoming | 6,650 | $35.2K | 0.01% |
| Headlands Technologies LLC | 2,301 | $12.2K | 0.00% |
| Group One Trading, L.P. | 1,495 | $7.92K | 0.00% |
| CIBC Private Wealth Group, LLC | 775 | $4.09K | 0.00% |
| GWM Advisors LLC | 717 | $3.80K | 0.00% |
Sold out (9)
Institutions that held Puma Biotechnology, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Affinity Asset Advisors, LLC | 202,349 | $876.2K |
| Citadel Advisors LLC | 121,796 | $527.4K |
| 683 Capital Management, LLC | 55,005 | $238.2K |
| Franklin Resources Inc | 19,162 | $83.0K |
| Engineers Gate Manager LP | 19,077 | $82.6K |
| Boothbay Fund Management, LLC | 17,895 | $77.5K |
| Royal Bank of Canada | 5,100 | $22.0K |
| Lindbrook Capital, LLC | 2,793 | $12.1K |
| JNBA Financial Advisors | 4 | $18 |